Loading...
Market
Public response to Pfizer vaccine study by early 2025?
2
Resolution / Starting Odds
Increased vaccine hesitancy • 25%
No significant change • 25%
Increased trust in vaccines • 25%
Public divided • 25%
Public opinion polls or major news analyses
Story
Study Finds 55 Undeclared Elements, Including 11 Heavy Metals and Arsenic, in Pfizer COVID Vaccine Batches
Oct 14, 2024, 11:35 PM
A recent peer-reviewed study has revealed concerning findings regarding COVID-19 vaccines, indicating the presence of at least 55 undeclared chemical elements, including 11 heavy metals. The study highlights that these elements are potentially harmful, raising alarms about vaccine safety. Additionally, the research claims that all tested batches of the Pfizer vaccine contained arsenic, with levels exceeding the safe exposure limit for drinking water set by the Environmental Protection Agency (EPA) in the United States. These discoveries have sparked significant discussion regarding the composition of COVID-19 vaccines and their implications for public health.
View original story
Similar markets
Increased trust in vaccines • 25%
Decreased trust in vaccines • 25%
Increased demand for transparency • 25%
Indifference • 25%
No response • 25%
Denial of contamination claims • 25%
Acknowledgement of contamination and corrective measures • 25%
Legal action against claimants • 25%
Increased trust • 25%
Decreased trust • 25%
No significant change • 25%
Mixed responses • 25%
Mostly positive • 25%
Mostly negative • 25%
Mixed • 25%
Indifferent • 25%
Majority critical of vaccinations • 25%
Majority supportive of vaccinations • 25%
Balanced view with no clear majority • 25%
Focus on study methodology • 25%
Implement moratorium • 25%
Conduct further research • 25%
Ignore findings • 25%
Issue public warnings • 25%
Increased trust in mRNA vaccines • 25%
Decreased trust in mRNA vaccines • 25%
Trust remains unchanged • 25%
Mixed opinions • 25%
Widespread support • 25%
Mixed reactions • 25%
Predominantly negative • 25%
Major public protests • 25%
Strong Support • 25%
Moderate Support • 25%
Moderate Opposition • 25%
Strong Opposition • 25%
Majority supportive • 25%
Majority opposed • 25%
Evenly split • 25%
No significant response • 25%
Increase trust • 25%
Decrease trust • 25%
No significant change • 25%
Mixed impact • 25%
Acknowledge and propose further studies • 25%
Deny correlation and defend vaccine safety • 25%
Announce new vaccine formulations • 25%
No official response • 25%